GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c; Guides Q1 Revs Below the Street

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q4 EPS of $0.09, $0.01 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $213.3 million versus the consensus estimate of $217.53 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q1 2022 revenue of ~$200 million, versus the consensus of $227.92 million.

For the year, the company sees ~23% year-over-year growth.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Lumentum shares rise on analyst upgrades, AI demand outlook
• UBS cuts KOSPI target by nearly 10% to reflect higher rates